Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in hematology and oncology. Spectrum currently markets six hematology/oncology drugs, and has an advanced stage pipeline that has the potential to transform the company. Spectrum's strong track record for in-licensing and acquiring differentiated drugs, and expertise in clinical development have generated a robust, diversified, and growing pipeline of product candidates in advanced-stage Phase 2 and Phase 3 studies. More information on Spectrum is available at www.sppirx.com.
Company: | SPECTRUM PHARMACEUTICALS | |||||
Headquarters Address: | 11500 S. Eastern Avenue #240 | |||||
| Henderson, NV 89052 | ||||||
Main Telephone: | 949-743-9244 | |||||
Website: | ||||||
Ticker: | SPPI (Nasdaq) | |||||
Type of Organization: | Public | |||||
Industry: | Pharmaceuticals | |||||
Key Executives: | President and CEO: Joseph Turgeon | |||||
Contact: | Shiv Kapoor | |||||
Phone: | 702-835-6300 | |||||
Email: | ||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20180427005158/en/
